Bentham Science Publishers, Current Drug Targets, 7(9), p. 532-547
DOI: 10.2174/138945008784911787
Full text: Download
There has been a surge of interest in the therapeutic targeting of the Wnt pathway following the demonstration that it is activated in a wide variety of tumors and that blocking aberrant signaling promoted tumor cell apoptosis or differentiation. This review describes recent therapeutic approaches and discusses potential opportunities for intervention at multiple levels within the Wnt pathway.